Your search returned 20 results.

Results
	1.	Cost-effectiveness of gefitinib, icotinib, and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China. [electronic resource] by Lu, Shun Ye, Ming Ding, Lieming Tan, Fenlai Fu, Jie Wu, Bin Producer: 20180220 In: Oncotarget vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Efficacy of icotinib in advanced lung squamous cell carcinoma. [electronic resource] by Liang, Shuai Xu, Yan Tan, Fenlai Ding, Lieming Ma, Yongbin Wang, Mengzhao Producer: 20191114 In: Cancer medicine vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Icotinib, a selective EGF receptor tyrosine kinase inhibitor, for the treatment of non-small-cell lung cancer. [electronic resource] by Tan, Fenlai Shi, Yuankai Wang, Yinxiang Ding, Lieming Yuan, Xiaobin Sun, Yan Producer: 20151109 In: Future oncology (London, England) vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Simultaneous determination of a novel c-Met/AXL dual-target small-molecule inhibitor BPI-9016M and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry: Application in a pharmacokinetic study in Chinese advanced solid tumor patients. [electronic resource] by Cui, Xinge Zheng, Xin Jiang, Ji Tan, Fenlai Ding, Lieming Hu, Pei Producer: 20171204 In: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences vol. 1068-1069 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Determination of BPI15086 and its metabolite in human plasma by ultra-high performance liquid chromatography-MS/MS and its application to a pharmacokinetic study. [electronic resource] by Wang, Shaoyuan Zheng, Xin Zhang, Yanbao Hu, Pei Ding, Lieming Mao, Li Jiang, Ji Producer: 20190830 In: Bioanalysis vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Antisense p53 transduction leads to overexpression of bcl-2 and dexamethasone resistance in multiple myeloma. [electronic resource] by Iyer, Rajaraman Ding, LieMing Batchu, Ramesh B Naugler, Scott Shammas, Masood A Munshi, Nikhil C Producer: 20030303 In: Leukemia research vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	BPI-9016M, a c-Met inhibitor, suppresses tumor cell growth, migration and invasion of lung adenocarcinoma via miR203-DKK1. [electronic resource] by Zhang, Panpan Li, Shaolei Lv, Chao Si, Jiahui Xiong, Ying Ding, Lieming Ma, Yuanyuan Yang, Yue Producer: 20190905 In: Theranostics vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Limited reliability of lipid-laden macrophage index restricts its use as a test for pulmonary aspiration: comparison with a simple semiquantitative assay. [electronic resource] by Ding, Yiling Simpson, Pippa M Schellhase, Dennis E Tryka, A Francine Ding, Lieming Parham, David M Producer: 20030612 In: Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	BPI-3016, a novel long-acting hGLP-1 analogue for the treatment of Type 2 diabetes mellitus. [electronic resource] by Ding, Lieming Lu, Sisi Wang, Yanping Chen, Haibo Long, Wei Ma, Cunbo He, Erlong Yan, Dan Tan, Fenlai Producer: 20180112 In: Pharmacological research vol. 122 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer. [electronic resource] by Hu, Xingsheng Zheng, Xin Yang, Sheng Wang, Lin Hao, Xuezhi Cui, Xinge Ding, Lieming Mao, Li Hu, Pei Shi, Yuankai Producer: 20210126 In: Journal of hematology & oncology vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Icotinib (BPI-2009H), a novel EGFR tyrosine kinase inhibitor, displays potent efficacy in preclinical studies. [electronic resource] by Tan, Fenlai Shen, Xiaoyan Wang, Dechang Xie, Guojian Zhang, Xiaodong Ding, Lieming Hu, Yunyan He, Wei Wang, Yanping Wang, Yinxiang Producer: 20120921 In: Lung cancer (Amsterdam, Netherlands) vol. 76 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Icotinib inhibits EGFR signaling and alleviates psoriasis-like symptoms in animal models. [electronic resource] by Tan, Fenlai Yang, Guiqun Wang, Yanping Chen, Haibo Yu, Bo Li, He Guo, Jing Huang, Xiaoling Deng, Yifang Yu, Pengxia Ding, Lieming Producer: 20180815 In: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 98 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Synthesis and biological evaluation of crown ether fused quinazoline analogues as potent EGFR inhibitors. [electronic resource] by Hu, Shaojing Xie, Guojian Zhang, Don X Davis, Charles Long, Wei Hu, Yunyan Wang, Fei Kang, Xinshan Tan, Fenlai Ding, Lieming Wang, Yinxiang Producer: 20130204 In: Bioorganic & medicinal chemistry letters vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	A Phase I Study of the Safety and Pharmacokinetics of Higher-Dose Icotinib in Patients With Advanced Non-Small Cell Lung Cancer. [electronic resource] by Liu, Jian Wu, Lihua Wu, Guolan Hu, Xingjiang Zhou, Huili Chen, Junchun Zhu, Meixiang Xu, Wei Tan, Fenlai Ding, Lieming Wang, Yinxiang Shentu, Jianzhong Producer: 20171101 In: The oncologist vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: Results of phase I dose-escalation study. [electronic resource] by Zhou, Lin He, Jiazhuo Xiong, Weijie Liu, Yongmei Xiang, Jing Yu, Qin Liang, Maozhi Zhou, Xiaojuan Ding, Zhenyu Huang, Meijuan Ren, Li Zhu, Jiang Li, Lu Hou, Mei Ding, Lieming Tan, Fenlai Lu, You Producer: 20171218 In: Lung cancer (Amsterdam, Netherlands) vol. 96 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Phase 1 trial of vorolanib (CM082) in combination with everolimus in patients with advanced clear-cell renal cell carcinoma. [electronic resource] by Sheng, Xinan Yan, Xieqiao Chi, Zhihong Cui, Chuanliang Si, Lu Tang, Bixia Li, Siming Mao, Lili Lian, Bin Wang, Xuan Bai, Xue Zhou, Li Kong, Yan Dai, Jie Ding, Lieming Mao, Li Guo, Jun Producer: 20210401 In: EBioMedicine vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study. [electronic resource] by Hu, Xingsheng Zhang, Li Shi, Yuankai Zhou, Caicun Liu, Xiaoqing Wang, Dong Song, Yong Li, Qiang Feng, Jifeng Qin, Shukui Xv, Nong Zhou, Jianying Zhang, Li Hu, Chunhong Zhang, Shucai Luo, Rongcheng Wang, Jie Tan, Fenlai Wang, Yinxiang Ding, Lieming Sun, Yan Producer: 20160617 In: PloS one vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC). [electronic resource] by Hu, Xingsheng Han, Baohui Gu, Aiqin Zhang, Yiping Jiao, Shun Chang Wang, Chang-Li He, Jintao Jia, Xueke Zhang, Li Peng, Jiewen Wu, Meina Ying, Kejing Wang, Junye Ma, Kewei Zhang, Shucai You, Changxuan Tan, Fenlai Wang, Yinxiang Ding, Lieming Sun, Yan Producer: 20150723 In: Lung cancer (Amsterdam, Netherlands) vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Routine-Dose and High-Dose Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 21-L858R Mutation: the Randomized, Phase II, INCREASE Trial. [electronic resource] by Li, Xi Zhang, Li Jiang, Da Wang, Yan Zang, Aimin Ding, Cuimin Zhao, Min Su, Wuyun Zhang, Yan Zhong, Diansheng Wu, Jin Zhang, Cuiying An, Guangyu Hu, Xingsheng Cheng, Gang Wang, Huaqing Li, Yongqun He, Xiaohui Liu, Junli Liang, Li Ding, Lieming Mao, Li Zhang, Shucai Producer: 20210914 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial. [electronic resource] by Shi, Yuankai Zhang, Li Liu, Xiaoqing Zhou, Caicun Zhang, Li Zhang, Shucai Wang, Dong Li, Qiang Qin, Shukui Hu, Chunhong Zhang, Yiping Chen, Jianhua Cheng, Ying Feng, Jifeng Zhang, Helong Song, Yong Wu, Yi-Long Xu, Nong Zhou, Jianying Luo, Rongcheng Bai, Chunxue Jin, Yening Liu, Wenchao Wei, Zhaohui Tan, Fenlai Wang, Yinxiang Ding, Lieming Dai, Hong Jiao, Shunchang Wang, Jie Liang, Li Zhang, Weimin Sun, Yan Producer: 20131104 In: The Lancet. Oncology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 20 results.